{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:03:45Z","timestamp":1784901825794,"version":"3.55.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cost-effectiveness analyses on cell salvage for cesarean delivery to inform national and societal guidelines on obstetric blood management are lacking. This study examined the cost-effectiveness of cell salvage strategies in obstetric hemorrhage from a societal perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Markov decision analysis modeling compared the cost-effectiveness of three strategies: use of cell salvage for every cesarean delivery, cell salvage use for high-risk cases, and no cell salvage. A societal perspective and lifetime horizon was assumed for the base case of a 26-yr-old primiparous woman presenting for cesarean delivery. Each strategy integrated probabilities of hemorrhage, hysterectomy, transfusion reactions, emergency procedures, and cell salvage utilization; utilities for quality of life; and costs at the societal level. One-way and Monte Carlo probabilistic sensitivity analyses were performed. A threshold of $100,000 per quality-adjusted life-year gained was used as a cost-effectiveness criterion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cell salvage use for cases at high risk for hemorrhage was cost-effective (incremental cost-effectiveness ratio, $34,881 per quality-adjusted life-year gained). Routine cell salvage use for all cesarean deliveries was not cost-effective, costing $415,488 per quality-adjusted life-year gained. Results were not sensitive to individual variation of other model parameters. The probabilistic sensitivity analysis showed that at the $100,000 per quality-adjusted life-year gained threshold, there is more than 85% likelihood that cell salvage use for cases at high risk for hemorrhage is favorable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of cell salvage for cases at high risk for obstetric hemorrhage is economically reasonable; routine cell salvage use for all cesarean deliveries is not. These findings can inform the development of public policies such as guidelines on management of obstetric hemorrhage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aln.0000000000001981","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T19:23:02Z","timestamp":1512156182000},"page":"328-337","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":54,"title":["Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage"],"prefix":"10.1097","volume":"128","author":[{"given":"Grace","family":"Lim","sequence":"first","affiliation":[{"name":"From the Department of Anesthesiology (G.L., V.M., J.H.W.) and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Magee\u2013Womens Research Institute and Foundation (F.L.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania (K.J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladyslav","family":"Melnyk","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology (G.L., V.M., J.H.W.) and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Magee\u2013Womens Research Institute and Foundation (F.L.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania (K.J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca L.","family":"Facco","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology (G.L., V.M., J.H.W.) and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Magee\u2013Womens Research Institute and Foundation (F.L.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania (K.J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Waters","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology (G.L., V.M., J.H.W.) and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Magee\u2013Womens Research Institute and Foundation (F.L.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania (K.J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology (G.L., V.M., J.H.W.) and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Magee\u2013Womens Research Institute and Foundation (F.L.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania (K.J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20241223","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1213\/ANE.0000000000000786","article-title":"Cell salvage in obstetrics.","volume":"121","year":"2015","journal-title":"Anesth Analg"},{"key":"R3-20241223","first-page":"40","article-title":"Indications and contraindications of cell salvage.","volume":"44","year":"2004","journal-title":"Transfusion"},{"key":"R4-20241223","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijoa.2007.08.001","article-title":"Cell salvage in obstetrics.","volume":"17","year":"2008","journal-title":"Int J Obstet Anesth"},{"key":"R5-20241223","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/bja\/aeq244","article-title":"Cell salvage as part of a blood conservation strategy in anaesthesia.","volume":"105","year":"2010","journal-title":"Br J Anaesth"},{"key":"R7-20241223","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bja\/80.2.195","article-title":"Blood salvage during caesarean section.","volume":"80","year":"1998","journal-title":"Br J Anaesth"},{"key":"R8-20241223","doi-asserted-by":"crossref","first-page":"e74876","DOI":"10.1371\/journal.pone.0074876","article-title":"Impact on infants\u2019 cognitive development of antenatal exposure to iron deficiency disorder and common mental disorders.","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"R9-20241223","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-6215-16-5","article-title":"Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: Study protocol for a randomised controlled trial.","volume":"16","year":"2015","journal-title":"Trials"},{"key":"R10-20241223","first-page":"398","article-title":"Association between maternal anaemia and postpartum depression in an urban sample of pregnant women in Iran.","volume":"31","year":"2013","journal-title":"J Health Popul Nutr"},{"key":"R11-20241223","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/AOG.0000000000000729","article-title":"Red blood cell salvage during obstetric hemorrhage.","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R12-20241223","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/BRS.0b013e3182767c8c","article-title":"Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.","volume":"38","year":"2013","journal-title":"Spine (Phila Pa 1976)"},{"key":"R13-20241223","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/AOG.0000000000000465","article-title":"Cost savings of red cell salvage during cesarean delivery.","volume":"124","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R14-20241223","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the panel on cost-effectiveness in health and medicine.","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"R16-20241223","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0168-8510(94)00677-7","article-title":"A note on the depreciation of the societal perspective in economic evaluation of health care.","volume":"33","year":"1995","journal-title":"Health Policy"},{"key":"R17-20241223","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/AOG.0000000000000564","article-title":"Pregnancy-related mortality in the United States, 2006\u20132010.","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R18-20241223","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1111\/trf.13791","article-title":"Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage.","volume":"56","year":"2016","journal-title":"Transfusion"},{"key":"R21-20241223","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/aogs.12352","article-title":"Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.","volume":"93","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R22-20241223","first-page":"1039","article-title":"American College of O, Gynecologists: ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: Postpartum hemorrhage.","volume":"108","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R23-20241223","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: Definition and review.","volume":"33","year":"2005","journal-title":"Crit Care Med"},{"key":"R24-20241223","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jval.2013.06.014","article-title":"Lifetime cost-effectiveness of trial of labor after cesarean in the United States.","volume":"16","year":"2013","journal-title":"Value Health"},{"key":"R25-20241223","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00404-014-3451-x","article-title":"Calculating probability of requiring allogeneic blood transfusion using three preoperative risk factors on cesarean section for placenta previa.","volume":"291","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"R26-20241223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/tmrv.2001.19946","article-title":"Proceedings of a consensus conference: Prevention of post-transfusion CMV in the era of universal leukoreduction.","volume":"15","year":"2001","journal-title":"Transfus Med Rev"},{"key":"R27-20241223","first-page":"671","article-title":"Current risk for transfusion transmitted infections.","volume":"14","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"R28-20241223","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.","volume":"42","year":"2002","journal-title":"Transfusion"},{"key":"R29-20241223","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1537-2995.2007.01248.x","article-title":"Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: The American Red Cross experience (2004\u20132006).","volume":"47","year":"2007","journal-title":"Transfusion"},{"key":"R30-20241223","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1537-2995.2010.02816.x","article-title":"Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients.","volume":"51","year":"2011","journal-title":"Transfusion"},{"key":"R31-20241223","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/01.SMJ.0000163309.53317.B8","article-title":"Postpartum hemorrhage after cesarean delivery: An analysis of risk factors.","volume":"98","year":"2005","journal-title":"South Med J"},{"key":"R32-20241223","first-page":"289","article-title":"Fluid overload is associated with increases in length of stay and hospital costs: Pooled analysis of data from more than 600 US hospitals.","volume":"5","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"R33-20241223","first-page":"622","article-title":"Identifying risk factors for peripartum cesarean hysterectomy: A population-based study.","volume":"48","year":"2003","journal-title":"J Reprod Med"},{"key":"R34-20241223","first-page":"CD001888","article-title":"Cell salvage for minimising perioperative allogeneic blood transfusion.","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-20241223","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/CIRCULATIONAHA.110.985655","article-title":"Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.","volume":"123","year":"2011","journal-title":"Circulation"},{"key":"R36-20241223","doi-asserted-by":"crossref","first-page":"e58577","DOI":"10.1371\/journal.pone.0058577","article-title":"At what price? A cost-effectiveness analysis comparing trial of labour after previous caesarean versus elective repeat caesarean delivery.","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"R37-20241223","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/jwh.2009.1404","article-title":"Pelvic floor consequences of cesarean delivery on maternal request in women with a single birth: A cost-effectiveness analysis.","volume":"19","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"R38-20241223","first-page":"932","article-title":"Cost-effectiveness of a trial of labor after previous cesarean.","volume":"97","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R39-20241223","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00192-004-1203-3","article-title":"Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia: A decision analysis.","volume":"16","year":"2005","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R40-20241223","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(03)15385-8","article-title":"Cost utility of prenatal diagnosis and the risk-based threshold.","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"R41-20241223","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.transci.2013.04.045","article-title":"Cost-effectiveness and budget impact study of solvent\/detergent (SD) treated plasma (octaplasLG\u00ae) versus fresh-frozen plasma (FFP) in any patient receiving transfusion in Canada.","volume":"51","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"R42-20241223","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0223(199908)19:8<711::AID-PD614>3.0.CO;2-V","article-title":"Preferences of women facing a prenatal diagnostic choice: Long-term outcomes matter most.","volume":"19","year":"1999","journal-title":"Prenat Diagn"},{"key":"R43-20241223","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/S0002-9378(03)00833-0","article-title":"Vaginal birth after cesarean section: Trial of labor or repeat cesarean section? A decision analysis.","volume":"189","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R44-20241223","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2012.06.048","article-title":"Gestational diabetes screening with the new IADPSG guidelines: A cost-effectiveness analysis.","volume":"207","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R45-20241223","doi-asserted-by":"crossref","first-page":"282.e1","DOI":"10.1016\/j.ajog.2011.06.051","article-title":"Treating mild gestational diabetes mellitus: A cost-effectiveness analysis.","volume":"205","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R46-20241223","doi-asserted-by":"crossref","first-page":"d2202","DOI":"10.1136\/bmj.d2202","article-title":"Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: Cost effectiveness analysis.","volume":"342","year":"2011","journal-title":"BMJ"},{"key":"R47-20241223","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.L.00400","article-title":"Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.","volume":"95","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"R48-20241223","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2393-10-3","article-title":"Cost-effectiveness of external cephalic version for term breech presentation.","volume":"10","year":"2010","journal-title":"BMC Pregnancy Childbirth"},{"key":"R49-20241223","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?","volume":"46","year":"2008","journal-title":"Med Care"},{"key":"R50-20241223","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness: The curious resilience of the $50,000-per-QALY threshold.","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"R51-20241223","first-page":"201","article-title":"Economic analysis of an intraoperative cell salvage service.","volume":"98","year":"2004","journal-title":"Anesth Analg"},{"key":"R52-20241223","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2011.03111.x","article-title":"The volume of returned red blood cells in a large blood salvage program: Where does it all go?","volume":"51","year":"2011","journal-title":"Transfusion"},{"key":"R53-20241223","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1213\/01.ane.0000258039.79028.7c","article-title":"An economic analysis of costs associated with development of a cell salvage program.","volume":"104","year":"2007","journal-title":"Anesth Analg"},{"key":"R54-20241223","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijoa.2012.05.003","article-title":"The economic benefits of cell salvage in obstetric haemorrhage.","volume":"21","year":"2012","journal-title":"Int J Obstet Anesth"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/128\/2\/328\/366353\/20180200_0-00021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?volume=128&page=328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:17:23Z","timestamp":1784899043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ALN.0000000000001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0000000000001981","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}